We are skilled at finding senior executives and experts, renowned scientists, clinicians and researchers worldwide, and assessing them from both a leadership and scientific perspective.
Whether you are a start-up, an established corporation, or a CDMO, working on pre-clinical or clinical development, or commercialisation, we’ll help you build collaborative teams. We are skilled in customising our approach to attract diverse, globally-experienced leaders for science-driven environments.
New business models require collaborative approaches to pipeline innovation, manufacturing and supply, and myriad bench-to-bedside translations. This matrix of layered initiatives requires leaders at all levels of the organisation to be capable of cutting across traditional disciplines through influence, persuasion and compromise.
Global patient demographics, emerging market demands and opportunities, and an increasingly female talent pool require inclusive leadership. Business leaders must become adept at recognising and prioritising the importance of diversity to harness its advantages for business and society.
When it comes to sustainability, we aspire to the same standards as our clients. We are proud to have been awarded a Bronze rating by Ecovadis in 2022.
Big data collection and usage; digitalization; and artificial intelligence in the entire life-cycle of therapies, from development to the point of patient access, are unstoppable trends. Wielding these technology tools in a meaningful way requires innovation leadership that is balanced by well-defined change management skills and a keen ability to prioritise.
Global patient demographics, emerging market demands and opportunities, and an increasingly female talent pool require inclusive leadership. Business leaders must become adept at recognising and prioritising the importance of diversity to harness its advantages for business and society.
When it comes to sustainability, we aspire to the same standards as our clients. We are proud to have been awarded a Bronze rating by Ecovadis in 2022.
Stryker has started a limited market release of its Mako RPS handheld robotic system for total knee procedures, the company said Monday. Mako RPS, short for robotic power system, is aimed at surgeons who are interested in robotic technology but want the familiarity of a manual power tool, the company said.
The European Life Sciences Coalition (ELSC), which launched today in association with Belgium-based private capital association Invest Europe, also counts the likes of Forbion, Omega Funds and Cooley among its members. These members represent a combined 24 billion euros ($28.6 billion) in life science assets.
Sanofi announced changes to its leadership following a meeting of its Board of Directors on February 11, 2026. The Board decided not to renew the director mandate of Paul Hudson, whose tenure as Chief Executive Officer will end on February 17, 2026.
